Sirolimus: The Evidence for Clinical Pharmacokinetic Monitoring

Author： Sunita Bond Stenton   Partovi Nilufar   Ensom Mary H.H.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.44, Iss.8, 2005-01, pp. : 769-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can Pharmacokinetic Monitoring Improve Clinical Use of Fluorouracil?

By Young A.M.   Daryanani S.   Kerr D.J.  

Clinical Pharmacokinetics, Vol. 36, Iss. 6, 1999-06 ,pp. : 391-398

Adis International

Access to resources Recommend Favorite

Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia?

By Schwenger Erin   Dumontet Jane   Ensom Mary H.H.  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 415-428

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Sirolimus

By Mahalati K.   Kahan B.D.  

Clinical Pharmacokinetics, Vol. 40, Iss. 8, 2001-01 ,pp. : 573-585

Adis International

Access to resources Recommend Favorite

Efavirenz and Nevirapine in HIV-1 Infection: Is There a Role for Clinical Pharmacokinetic Monitoring?

By Dahri Karen   Ensom Mary H.H.  

Clinical Pharmacokinetics, Vol. 46, Iss. 2, 2007-01 ,pp. : 109-132

Adis International

Access to resources Recommend Favorite

Sirolimus Population Pharmacokinetic/Pharmacogenetic Analysis and Bayesian Modelling in Kidney Transplant Recipients

By Djebli Nassim  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1135-1148

Adis International

Access to resources Recommend Favorite